Background There has been a growing interest in granting prescribing rights to pharmacists
as a strategy to improve healthcare access. Researchers continue to explore the impact and …

Despite efforts to expand naloxone access, opioid-related overdoses remain a significant
contributor to mortality. We study state efforts to expand naloxone distribution through …

Background Recent legislative advances now permit pharmacists to prescribe tobacco
cessation medications in 17 states. While national initiatives are underway to prepare the …

Policies that increase contraceptive access for young women and their partners are a
potentially low-cost way of reducing unintended pregnancies and improving later life …

PURPOSE In 2017, the National Cancer Institute (NCI) funded the Cancer Center Cessation
Initiative (C3I) to implement and expand tobacco treatment programs in routine oncology …

Objective To characterize (1) tobacco cessation content, delivery, and assessment
methods,(2) faculty perceptions of content adequacy, and (3) faculty interest in enhancing …

To address gaps in care for individuals from under-resourced communities
disproportionately affected by tobacco use, this pharmacist-led demonstration project …

Tobacco use remains a leading preventable cause of morbidity and mortality, with
pharmacotherapy and counseling recognized as effective cessation aids. Yet, the potential …

Background The role of pharmacists in tobacco cessation has grown substantially in recent
years, now including the ability to prescribe medications in many states. Although …

Prostate cancer is the leading cancer in men. Continued tobacco use after prostate cancer
diagnosis may affect a patient's treatment outcomes, quality of life, and mortality. Despite the …